1. Home
  2. SNSE vs AREB Comparison

SNSE vs AREB Comparison

Compare SNSE & AREB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNSE
  • AREB
  • Stock Information
  • Founded
  • SNSE 2005
  • AREB 2014
  • Country
  • SNSE United States
  • AREB United States
  • Employees
  • SNSE N/A
  • AREB N/A
  • Industry
  • SNSE Biotechnology: Pharmaceutical Preparations
  • AREB Plastic Products
  • Sector
  • SNSE Health Care
  • AREB Industrials
  • Exchange
  • SNSE Nasdaq
  • AREB Nasdaq
  • Market Cap
  • SNSE 10.8M
  • AREB 10.4M
  • IPO Year
  • SNSE 2021
  • AREB N/A
  • Fundamental
  • Price
  • SNSE $8.17
  • AREB $1.31
  • Analyst Decision
  • SNSE Strong Buy
  • AREB
  • Analyst Count
  • SNSE 3
  • AREB 0
  • Target Price
  • SNSE $86.67
  • AREB N/A
  • AVG Volume (30 Days)
  • SNSE 12.9K
  • AREB 709.6K
  • Earning Date
  • SNSE 08-05-2025
  • AREB 08-13-2025
  • Dividend Yield
  • SNSE N/A
  • AREB N/A
  • EPS Growth
  • SNSE N/A
  • AREB N/A
  • EPS
  • SNSE N/A
  • AREB N/A
  • Revenue
  • SNSE N/A
  • AREB $9,887,755.00
  • Revenue This Year
  • SNSE N/A
  • AREB N/A
  • Revenue Next Year
  • SNSE N/A
  • AREB N/A
  • P/E Ratio
  • SNSE N/A
  • AREB N/A
  • Revenue Growth
  • SNSE N/A
  • AREB N/A
  • 52 Week Low
  • SNSE $5.00
  • AREB $1.10
  • 52 Week High
  • SNSE $17.40
  • AREB $231.75
  • Technical
  • Relative Strength Index (RSI)
  • SNSE 50.67
  • AREB 37.85
  • Support Level
  • SNSE $8.76
  • AREB $1.13
  • Resistance Level
  • SNSE $9.27
  • AREB $1.32
  • Average True Range (ATR)
  • SNSE 0.52
  • AREB 0.13
  • MACD
  • SNSE -0.00
  • AREB 0.06
  • Stochastic Oscillator
  • SNSE 42.84
  • AREB 38.95

About SNSE Sensei Biotherapeutics Inc.

Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).

About AREB American Rebel Holdings Inc.

American Rebel Holdings Inc develops self-defense, safe storage, and patriotic product areas using a wholesale distribution network, utilizing personal appearances, musical venue performances, as well as e-commerce and television. It designs, manufactures, and markets concealed carry products. It offers products ranging in Backpacks, jackets, coats, and Others. The Company views its operations and manages its business as one operating segment engaged in patriotic goods, comprised of safes, soft goods, and beer.

Share on Social Networks: